Mr. Chair, it is my time, and I'm asking the minister if she personally agrees with that testimony from NACI.
I am not manipulating NACI's testimony. NACI's testimony last night was that the failure to access enough vaccines early on forced the decision to change the access to the Pfizer vaccine off-label to extend that second dose. That was her testimony. I'm asking the minister if she agrees with that testimony.